Impact of Direct-to-Consumer Advertising on Prescription Drug Spending June 10, 2003 Report A new study by researchers at Harvard University and the Massachusetts Institute of Technology looks at the effect of direct-to-consumer (DTC) advertising on spending for prescription drugs. The study found that, on average, a 10% increase in DTC advertising of drugs within a therapeutic drug class resulted in a 1% increase in sales of the drugs in that class.
Demand Effects of Recent Changes in Prescription Drug Promotion June 1, 2003 Report The rapid increase in DTC advertising for prescription drugs has focused attention on its role in drug spending and prescribing. A new study by researchers at Harvard University and the Massachusetts Institute of Technology looks at the effect of direct-to-consumer (DTC) advertising on spending for prescription drugs. The study found…
Medicare Prescription Drugs Through Private Drug-Only Plans: A Discussion with Actuaries May 31, 2003 Report Central to the current debate over Medicare prescription drug coverage is the role of private insurance plans in providing drug benefits to Medicare beneficiaries. This report offers views from health actuaries knowledgeable about the Medicare program and the prescription drug debate on key issues that emerge for potential plan sponsors,…
Kaiser Family Foundation/Harvard School of Public Health National Survey of the Public’s Views on Medicare May 31, 2003 Poll Finding Kaiser Family Foundation/Harvard School of Public Health National Survey of the Public’s Views on MedicareA new national survey by the Kaiser Family Foundation and the Harvard School of Public Health examines the public’s attitudes and opinions on issues related to the Medicare reform and prescription drug debate. The survey also…
Medicare and Prescription Drug Spending Chartpack May 31, 2003 Report This chartpack provides 2003 and 2006 estimates of total and out-of-pocket prescription drug spending by Medicare beneficiaries. The data and analysis for this chartpack, prepared by Actuarial Research Corporation, assume no change in current law.Chart Pack
Kaiser Family Foundation/Harvard School of Public Health National Survey of the Public’s Views on Medicare- Chartpack May 31, 2003 Report Kaiser Family Foundation/Harvard School of Public Health National Survey of the Public's Views on MedicareA national survey by the Kaiser Family Foundation and the Harvard School of Public Health examines the public's attitudes and opinions on issues related to the Medicare reform and prescription drug debate. The survey also takes…
The Financing of Pharmacy Plus Waivers: Trade Offs Between Expanding Rx Coverage and Global Caps in Medicaid April 30, 2003 Report Background Paper
Pharmacy Plus Waivers: Trade Offs Between Expanding Rx Coverage and Global Caps in Medicaid April 30, 2003 Issue Brief The Kaiser Commission on Medicaid and the Uninsured has been monitoring the development of the Pharmacy Plus waiver initiated by the Bush Administration in 2002 and tracking the states that have pending or approved plans. The Commission has developed some materials describing the initiative, examining the financing mechanism, and discussing…
The Financing of Pharmacy Plus Waivers: Implications for Seniors on Medicaid of Global Funding Caps April 29, 2003 Issue Brief This policy brief describes Pharmacy Plus waivers being considered by some states for their Medicaid program and their implications for Medicaid financing. These waivers offer an opportunity for prescription drug coverage for low-income seniors, but they also include a major change in the financing of care for all seniors on…
National ADAP Monitoring Project, Annual Report, April 2003 April 2, 2003 Report This report, the seventh in an annual series, provides an overview of the status of state-administered AIDS Drug Assistance Programs (ADAPs) and documents how these programs are responding to the changing fiscal, clinical and epidemiological dynamics of HIV/AIDS.ADAPs, authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency…